What is the appropriate management for an insulin‑dependent type 2 diabetic patient with a bicarbonate of 20 mEq/L, an anion gap of 23, blood glucose of 587 mg/dL, pH of 7.35, and beta‑hydroxybutyrate of 4.43 mmol/L?

Management of Euglycemic Diabetic Ketoacidosis

This patient has euglycemic diabetic ketoacidosis (DKA) and requires immediate treatment with intravenous insulin infusion, aggressive fluid resuscitation, and potassium replacement—do not withhold treatment based on the near-normal pH of 7.35.

Clinical Assessment

Your patient presents with:

• Blood glucose: 587 mg/dL (elevated but not severely)
• pH: 7.35 (borderline, just above acidotic threshold)
• Bicarbonate: 20 mEq/L (low, below normal 22-28)
• Anion gap: 23 (significantly elevated, normal <12)
• Beta-hydroxybutyrate (β-HB): 4.43 mmol/L (markedly elevated, diagnostic for ketoacidosis)

This constellation meets DKA criteria despite the relatively preserved pH and modest hyperglycemia. The elevated β-HB is the key diagnostic finding—β-HB >3.0 mmol/L confirms significant ketoacidosis 1, 2. The nitroprusside method for ketone detection is unreliable during treatment, making β-HB measurement the gold standard 3, 1.

Immediate Treatment Protocol

1. Insulin Therapy (Grade A Recommendation)

Start continuous IV regular insulin infusion immediately 3, 1:

• No priming bolus needed for mild-moderate DKA
• Infusion rate: 0.1 units/kg/hour
• Continue until all three criteria are met:
  • Glucose <200 mg/dL
  • Bicarbonate ≥18 mEq/L
  • pH >7.3 1, 2

Critical pitfall: Do not stop insulin when glucose normalizes. Your patient's β-HB of 4.43 mmol/L will take significantly longer to clear than hyperglycemia 3. Studies show that continuing insulin until β-HB <0.5 mmol/L produces faster ketosis resolution (5.9 vs 21.8 hours) 4.

2. Fluid Resuscitation (Grade A Recommendation)

Initial fluid therapy 3:

• 0.9% NaCl at 15-20 mL/kg/hour for the first hour (1-1.5 liters for average adult)
• After initial hour, switch to 0.45% NaCl at 4-14 mL/kg/hour if corrected sodium is normal/elevated
• Add 5-10% dextrose when glucose falls to 200-250 mg/dL 3

Two-bag method consideration: Recent evidence suggests using simultaneous dextrose and saline bags reduces hypoglycemia risk (30% vs 3%) and shortens hospital stay (5.9 vs 3.1 days) compared to traditional one-bag switching 5. This allows continued adequate insulin dosing without hypoglycemia.

3. Potassium Replacement (Grade A Recommendation)

Potassium management 3:

• Check serum potassium immediately
• If K+ <5.5 mEq/L and adequate urine output: Add 20-30 mEq/L to each liter of IV fluid (2/3 KCl, 1/3 KPO4)
• If K+ <3.3 mEq/L: Delay insulin until potassium corrected to prevent life-threatening arrhythmias
• Target range: 4-5 mEq/L

4. Bicarbonate Therapy (NOT Indicated)

Do not give bicarbonate 3, 1, 3:

• Your patient's pH is 7.35, which is >7.0
• Bicarbonate only considered if pH <6.9 (Grade B-C recommendation)
• Studies show no benefit in resolution time or outcomes when pH >7.0 6

Monitoring Protocol

Laboratory monitoring every 2-4 hours 3, 1:

• Venous pH (adequate for monitoring, typically 0.03 units lower than arterial)
• Serum electrolytes (Na+, K+, Cl-)
• Glucose
• Anion gap calculation
• β-HB levels (if available—superior to nitroprusside ketone testing)

Hourly bedside glucose checks until stable

Transition to Subcutaneous Insulin

Criteria for IV-to-subcutaneous transition 1, 2:

1. Glucose <200 mg/dL
2. Bicarbonate ≥18 mEq/L
3. pH >7.3
4. Anion gap <12 mEq/L

Critical consideration: Your patient's bicarbonate of 20 mEq/L is borderline. Recent evidence shows that bicarbonate ≤16 mEq/L at transition predicts failure (odds ratio 4.74) even with normalized anion gap 7. Wait until bicarbonate reaches ≥18 mEq/L before transitioning.

Transition protocol 1:

• Give subcutaneous basal insulin 2-4 hours before stopping IV insulin
• Add rapid-acting insulin with meals
• Overlap IV and subcutaneous insulin for 1-2 hours to prevent rebound ketoacidosis
• Abrupt discontinuation causes recurrent hyperglycemia

Type 2 Diabetes Specific Considerations

Since this is an insulin-dependent type 2 diabetic:

• Screen for precipitating factors: infection, medication non-adherence, SGLT2 inhibitor use (causes euglycemic DKA) 8, 9
• After resolution, may transition to multi-dose insulin regimen or potentially oral agents depending on previous control 3
• Discharge planning must include diabetes education to prevent recurrence 6, 10

Key Pitfalls to Avoid

1. Don't rely on glucose alone: β-HB of 4.43 mmol/L confirms severe ketoacidosis requiring full DKA treatment despite glucose of 587 mg/dL
2. Don't stop insulin prematurely: Continue until bicarbonate ≥18 mEq/L, not just glucose normalization
3. Don't forget dextrose: Add when glucose reaches 200-250 mg/dL to allow continued insulin administration
4. Don't transition too early: Bicarbonate must be ≥18 mEq/L; levels ≤16 mEq/L predict transition failure 7
5. Don't abruptly stop IV insulin: Overlap with subcutaneous insulin for 1-2 hours 1